Banyu Pharmaceutical Co., Ltd.
Records under this name other than the patents Banyu Pharmaceutical Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Back to Banyu Pharmaceutical Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,030,327 | Fused imidazole derivative Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,799,820 | 2-Heterocycle-substituted indole derivatives for treating diabetes and associated conditions Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,268,842 | Fused ring 4-oxopyrimidine derivative Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,935,708 | Dihydropyrazolopyrimidinone Derivatives Formerly held In force · High confidence | In force | High confidence | |
| US 7,960,402 | Carbamoyl-substituted spiro derivative Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,932,394 | Aryloxy-Substituted Benzimidazole Derivatives Formerly held In force · High confidence | In force | High confidence | |
| US 7,994,331 | Heterocycle-substituted benzimidazole derivative Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,198,281 | Crystalline Forms of Dihydropyrazolopyrimidinone Formerly held In force · High confidence | In force | High confidence | |
| US 8,106,086 | Indoledione derivative Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,101,621 | Aminopyridine derivatives having aurora a selective inhibitory action Formerly held In force · From the USPTO record | In force | From the USPTO record |